Evidence map›Paper›PMID 32973788›Full record

ArticleFrontiers in immunology2020

Infection of

Yanqing Le, Wenli Cao, Lu Zhou, Xin Fan, Qiangui Liu, Fusheng Liu, Xiaoyan Gai, Chun Chang, Jing Xiong, Yafei Rao and 6 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. PGAM5 Modulates Macrophage Polarization, Aggravating Inflammation in COPD via the NF-κB Pathway.International journal of chronic obstructive pulmonary disease · 2025
    Article
  15. Frontiers in immunology · 2025
    Article
  16. Review
  17. Advances in the awareness of tuberculosis-associated chronic obstructive pulmonary disease.Chinese medical journal pulmonary and critical care medicine · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Yanqing LeDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Wenli CaoBeijing Geriatric Hospital, Beijing, China.
Lu ZhouDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Xin FanCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Qiangui LiuBeijing Geriatric Hospital, Beijing, China.
Fusheng LiuBeijing Geriatric Hospital, Beijing, China.
Xiaoyan GaiDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Chun ChangDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Jing XiongDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Yafei RaoDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Aling LiBeijing Geriatric Hospital, Beijing, China.
Wei XuBeijing Geriatric Hospital, Beijing, China.
Beibei LiuDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Tong WangDepartment of Thoracic Surgery, Peking University Third Hospital, Beijing, China.
Beinan WangCAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yongchang SunDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, China.
Beijing Geriatric Hospital · CNPeking University · CNPeking University Third Hospital · CNChinese Academy of Sciences · CNInstitute of Microbiology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary tuberculosis (PTB) is a risk factor for COPD. Our previous study revealed more severe emphysema in COPD patients (mostly smokers) with prior tuberculosis. However, the mechanisms of interactions between cigarette smoke (CS) and

Indexed as

SmokersAdultAgedAnimalsCase-Control StudiesCell LineCigarette SmokingDisease Models, AnimalFemaleHost-Pathogen InteractionsHumansMacrophages, AlveolarMaleMatrix Metalloproteinase 12Matrix Metalloproteinase 9Mice, Inbred C57BLmatrix metallopeptidase 12, mouseMatrix Metalloproteinase 12Matrix Metalloproteinase 9MMP12 protein, humanMMP9 protein, humanMmp9 protein, mouseTIMP1 protein, humanTimp1 protein, mouseTissue Inhibitor of Metalloproteinase-1chronic obstructive pulmonary diseasecigarette smokemacrophage polarizationmatrix metalloproteinaseMycobacterium tuberculosis

Identifiers

PMID32973788
PMCPMC7468417
OpenAlexW3081495856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.